Program – Day Two

The 4th WSC featured 16 sessions across 2 days, April 25 and 26, 2023. You can download the PDF program or explore day two below.

Impact of Sepsis Multidisciplinary Team Care on Patients Outcomes
Yaseen Arabi, Ministry of National Guard Health Affairs, Saudi Arabia

Initiation of Antimicrobial Stewardship in Resource-Constrained Environments: A Multidisciplinary Approach
Mirfin Mpundu, Director of ReAct Africa, Zambia

Sepsis Nurse – A Voice to Lead and Transform Care
Amanda Harley, Children’s Health Queensland, Australia

Family-Centered Care and Integration of Care Bundles
Kawaldip Sehmi, International Alliance of Patients’ Organization, United Kingdom

Early Rehabilitation in Sepsis: Journey to Return Activities and Functional Independence
Mohammed Alatwi, King Fahad Medical City, Saudi Arabia

Discussion by the Panelists

The Impact of the Pathogen and the Host Response on Survival
Jennifer Muszynski, Nationwide Children’s, United States of America

Sepsis Immune Endotypes
Mihai Netea, Radboud UMC, The Netherlands

The Effect of Risk Stratification and Timing of Host-Directed Therapy
Evangelos J. Giamarellos-Bourboulis, European Sepsis Alliance, Greece

The Pros of Platform Trials
Eirini Christaki, University of Ioannina, Greece

The Cons of Platform Trials 
Niels Riedemann, CEO InflaRx, Germany

The Key Drivers of Antimicrobial Resistance
Silvia Bertagnolio, World Health Organization, Switzerland

The Potential and Barriers to Antibiotic Stewardship
Ron Daniels, Infection Management Coalition, United Kingdom

The Potential of Biomarkers for Antimicrobials – Use and Diagnosis
Evdoxia Kyriazopoulou, National and Kapodistrian University of Athens, Greece

The Role of Biomarkers for Risk Stratification
Peter Pickkers, Radboud UMC, The Netherlands

The Evidence for the Role of Transcriptional Diagnostics
Tom van der Poll, Amsterdam UMC, The Netherlands

Learnings to Leverage the Fight Sepsis from an Integrated Health Service Perspective
Benedetta Allegranzi, World Health Organization, Switzerland

Preparing the EU to Manage Infections and Cross-Border Health Threats More Effectively
Velina Pendolovska, Directorate-General for Health and Food Safety, European Commission, Luxembourg

Lessons for Fighting Infections and Sepsis in Resource-Limited Settings
John Adabie Appiah, African Sepsis Alliance, Ghana

The Perspective of a Bedside Intensivist and the Potential of Telemedicine for Non-Covid Sepsis
Wiltrud Abels, Sepsis Stiftung, Germany

Learnings by a Caregiver and Researcher in Vietnam
Louise Thwaites, Asia Pacific Sepsis Alliance, Vietnam

Lessons for Clinical Research and Intensive Care Medicine
John Marshall, Unity Health, Canada

Discussion by the Panelists

The Burden of Long-Term Consequences of Sepsis and COVID-19
Jamie Rylance, World Health Organization, Switzerland

What Is Known on the Pathogenesis of Long-Term Sequelae by Infections and Sepsis?
Joost Wiersinga, Amsterdam UMC, The Netherlands

Toward Tailored Care for Sepsis Survivors
Erin Carlton, University of Michigan, United States of America

How Can We Mitigate Post-Sepsis and Post-COVID-Morbidity?
Hallie Prescott, University of Michigan, United States of America

Translating Post-Sepsis Care to Post-COVID-19 Care – The Role of Healthcare Systems
Stephanie Taylor, University of Michigan, United States of America

Disproportionate Burden of AMR Excess Deaths Experienced by Neonates in Low- and Middle-Income Countries
Ramanan Laxminarayan, University of Washington, United States of America

Incidence and Burden of Neonatal Sepsis in South Africa
Vanessa Quan, National Institute for Communicable Diseases, South Africa

Neonatal Sepsis and Treatment Challenges in India
Jeeva Sankar, All India Institute Of Medical Sciences, India

Invasive Bloodstream Infections and AMR in Africa: Approaches to Treatment and Next Steps
Uduak Okomo, MRC Unit, The Gambia

Next Steps for NeoSep
Julia Bielicki, St George’s University of London, United Kingdom

Panel Discussion
Participants: 

Ciarán Staunton, End Sepsis, United States of America
Melissa Mead, UK Sepsis Trust, United Kingdom
Ken Rothfield, Texas Health, United States of America
Luis Antonio Gorordo Del Sol, Sepsis Mexico, Mexico 
Doireann O’Mahony, Irish Sepsis Foundation, Ireland
Mary Steele, Sepsis Australia Consumer Advocacy Group & Queensland Paediatric Sepsis Program, Australia

An Epidemiology-Based Assessment of the Problem
Alan Tita, University of Alabama at Birmingham, United States of America

Sharing the Story
Video

Sepsis Awareness and the Importance of Advocacy – Perspective of a Midwife and Sepsis Survivor
Helen Cheyne, University of Stirling, United Kingdom

Early Detection and Management – What Does It Mean for Maternal Sepsis?
Maria Fernanda Escobar Vidarte, The International Federation of Gynecology and Obstetrics, Colombia

Can Changing the Health System’s Approach Improve Maternal Sepsis Outcomes in Argentina and Beyond?
Edgardo Abalos, Independent Researcher, Argentina

Can Changing the Health System’s Approach Improve Maternal Sepsis Outcomes in Lebanon and Beyond?
Sabina Abou Malham, Université de Sherbrooke, Canada

Discussion by the Panelists

The Perspective of the World Health Organization
Benedetta Allegranzi, World Health Organization, Switzerland

Healthcare in the Media: The Good, The Bad, and The Ugly
Katelyn Jetelina, Your Local Epidemiologist, United States of America

How to Target Specific Audiences for Improved Medical Messaging About Sepsis
Joachim Mueller-Jung, Science editor-in-chief, Frankfurter Allgemeine Zeitung, Germany

Effective Strategies for Better Medical Messaging in Media: Asia-Pacific
Naoyuki Matsuda, Global Sepsis Alliance, Japan

Effective Strategies for Better Medical Messaging in Media: Sub-Saharan Africa
Pedmia Shatu Tita, Global Initiative for Digital Inclusion and Communication, Cameroon

What Is the Role of the Journalist in Amplifying Positive Medical Messaging
Immaculate Forgwe, National Polytechnic Bamenda, Cameroon

Why Criteria for Diagnosing Pediatric Sepsis and the Social Determinants of Health Matter
Kusum Menon, University of Ottawa, Canada

Impact of Time to Source Control on Sepsis Mortality
Katherine Reitz, University of Pittsburgh Medical Center, United States of America

Does Rapid Sepsis Treatment Increase the Risk of Antimicrobial Resistance?
Hallie Prescott, University of Michigan, United States of America

Intravenous Vitamin C in Sepsis: the LOVIT Study
François Lamontagne, Université de Sherbrooke, Canada

Balanced Crystalloids or Saline for Sepsis?
Naomi Hammond, The George Institute for Global Health, Australia

Restrictive or Liberal Fluid in Sepsis: the CLOVERS Study
Ivor Douglas, Denver Health, United States of America

Closing Remarks: Imrana Malik, Program Chair & GSA Executive Member, United States of America